Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nuvo Pharmaceuticals Inc (NRI.TO)

Nuvo Pharmaceuticals Inc (NRI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nuvo Pharmaceuticals Inc 6733 Mississauga Road Suite 610 Mississauga ON L5N 6J5 CAN

P: 905-673-6980

Description:

Nuvo Pharmaceuticals Inc is a Canadian-focused healthcare company with a diversified portfolio of commercial products. The Company targets several therapeutic areas, including pain, allergy and dermatology. Its aims to in-license and acquire growth-oriented, complementary products for Canadian and international markets and to out-license select products in overseas markets. The company's head office is located in Mississauga, Ontario, Canada, its overseas operations are located in Dublin, Ireland and its manufacturing facility is located in Varennes, Quebec, Canada. The firm operates in three segments: Commercial Business, Production and Service Business and Licensing and Royalty Business.

Key Statistics

Overview:

Market Capitalization, $K 10,363
Shares Outstanding, K 11,388
Annual Sales, $ 0 K
Annual Net Income, $ 0 K
60-Month Beta 1.70
% of Institutional Shareholders 3.40%

Growth:

1-Year Return 102.22%
3-Year Return -74.22%
5-Year Return -82.67%
5-Year Revenue Growth 39.73%

Per-Share Information:

Latest Earnings Date 02/23/21
Earnings Per Share ttm -0.61
Dividend Payout Ratio 0.00%
Most Recent Split 1-65 on 05/09/13

NRI.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward 9.10
Price/Earnings to Growth N/A
Return-on-Equity % -32.85%
Return-on-Assets % -4.37%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 0.56
Book Value/Share N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar